{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:40:43Z","timestamp":1792449643664,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007059","name":"Univerzita Palack\u00e9ho v Olomouci","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejmech.2020.112872","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T02:58:31Z","timestamp":1601607511000},"page":"112872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Squaric acid analogues in medicinal chemistry"],"prefix":"10.1016","volume":"209","author":[{"given":"Jan","family":"Chas\u00e1k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"\u0160lachtov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8249-028X","authenticated-orcid":false,"given":"Milan","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Brul\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112872_bib1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/tcr.201500266","article-title":"Applications of chiral squaramides: from asymmetric organocatalysis to biologically active compounds","volume":"16","author":"Han","year":"2016","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ejmech.2020.112872_bib2","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1039\/c0cs00200c","article-title":"Squaramides: physical properties, synthesis and applications","volume":"40","author":"Storer","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2020.112872_bib3","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1039\/c3cs60153f","article-title":"Be squared: expanding the horizon of squaric acid-mediated conjugations","volume":"42","author":"Wurm","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2020.112872_bib4","first-page":"48","article-title":"Methods of synthesis of cyclobutenediones","volume":"11","author":"Mukkanti","year":"2005","journal-title":"Arkivoc"},{"key":"10.1016\/j.ejmech.2020.112872_bib5","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1021\/acscatal.7b00475","article-title":"Pushing the limits with squaramide-based organocatalysts in cyclic carbonate synthesis","volume":"7","author":"Sope\u00f1a","year":"2017","journal-title":"ACS Catal."},{"key":"10.1016\/j.ejmech.2020.112872_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/jhet.3173","article-title":"Microreview: pyrrol-3-yl squaraines (including indol-3-yl squaraines)","volume":"55","author":"Lynch","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib7","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1021\/ja805693p","article-title":"Chiral squaramide derivatives are excellent hydrogen bond donor catalysts","volume":"130","author":"Malerich","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112872_bib8","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.2174\/1385272820666160805113749","article-title":"Squaramide based organocatalysts in organic transformations","volume":"20","author":"Rouf","year":"2016","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib9","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1016\/j.tetlet.2018.08.034","article-title":"Squaramide catalyzed \u03b1-chiral amine synthesis","volume":"59","author":"Karahan","year":"2018","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2020.112872_bib10","doi-asserted-by":"crossref","first-page":"18290","DOI":"10.1002\/chem.201603382","article-title":"Cyclobutenones and benzocyclobutenones: versatile synthons in organic synthesis","volume":"22","author":"Chen","year":"2016","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2020.112872_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1039\/c2md20079a","article-title":"The use of phosphate bioisosteres in medicinal chemistry and chemical biology","volume":"3","author":"Elliott","year":"2012","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2020.112872_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1039\/9781782626657-00083","article-title":"Controlled and highly efficient preparation of carbohydrate-based vaccines: squaric acid chemistry is the way to go","volume":"42","author":"Kov\u00e1\u010d","year":"2017","journal-title":"Carbohydr. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.snb.2016.12.051","article-title":"Cyanine and squaric acid metal sensors","volume":"243","author":"Laramie","year":"2017","journal-title":"Sensor. Actuator. B Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/acs.biomac.7b01614","article-title":"Squaramide-based supramolecular materials for three-dimensional cell culture of human induced pluripotent stem cells and their derivatives","volume":"19","author":"Tong","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejmech.2020.112872_bib15","first-page":"1701","article-title":"Squaramide derivatives and their applications in ion recognition","volume":"26","author":"Qian","year":"2014","journal-title":"Prog. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib16","first-page":"235","article-title":"Squarate and croconate in designing one-and two-dimensional oxamidato-bridged copper (II) complexes: synthesis, crystal structures and magnetic properties of [Cu2(apox)(C4O4)(H2O)2]n\u00b7 nH2O and [Cu4(apox)2(C5O5)2]\u00b7 6H2O","volume":"4","author":"Castro","year":"2001","journal-title":"Comptes Rendus l\u2019Acad\u00e9mie Des Sci. IIC-Chemistry"},{"key":"10.1016\/j.ejmech.2020.112872_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jelechem.2017.10.023","article-title":"Squaric acid adsorption and oxidation at gold and platinum electrodes","volume":"819","author":"Cheuquep\u00e1n","year":"2018","journal-title":"J.\u00a0Electroanal. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib18","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1021\/ja01617a096","article-title":"Phenylcyclobutadienoquinone","volume":"77","author":"Smutny","year":"1955","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112872_bib19","first-page":"1833","article-title":"Synthesis of cyclobutanecarboxylic acids","author":"Julia","year":"1959","journal-title":"Bull. Soc. Chim. Fr."},{"key":"10.1016\/j.ejmech.2020.112872_bib20","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1021\/ja01522a083","article-title":"Diketocyclobutenediol","volume":"81","author":"Cohen","year":"1959","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112872_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.17229\/jdit.2017-0503-029","article-title":"Squaryl molecular metaphors-application to rational drug design and imaging agents","volume":"4","author":"Kitson","year":"2017","journal-title":"J.\u00a0Diagnostic Imaging Ther"},{"key":"10.1016\/j.ejmech.2020.112872_bib22","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1021\/j100681a007","article-title":"Conductance study of squaric acid aqueous dissociation","volume":"75","author":"Schwartz","year":"1971","journal-title":"J.\u00a0Phys. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib23","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1021\/ja960582d","article-title":"Nucleus-independent chemical shifts: a simple and efficient aromaticity probe","volume":"118","author":"Schleyer","year":"1996","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112872_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1021\/jo991267n","article-title":"Are oxocarbon dianions aromatic?","volume":"65","author":"Schleyer","year":"2000","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib25","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0040-4039(00)00084-8","article-title":"A\u00a0theoretical study of aromaticity in squaramide and oxocarbons","volume":"41","author":"Qui\u00f1onero","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2020.112872_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ejoc.200400539","article-title":"A\u00a0theoretical ab initio study of the capacity of several binding units for the molecular recognition of anions","volume":"2005","author":"Garau","year":"2005","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1021\/jm970504g","article-title":"Design and synthesis of [2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid (EAA-090), a potent N-Methyl-D-aspartate antagonist, via the use of 3-cyclobutene-1, 2-dione as an achiral \u03b1-amino acid bioisostere","volume":"41","author":"Kinney","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/jm8011799","article-title":"Prodrugs of perzinfotel with improved oral bioavailability","volume":"52","author":"Baudy","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib29","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cell.2019.07.028","article-title":"Structural basis for allosteric ligand recognition in the human CC chemokine receptor 7","volume":"178","author":"Jaeger","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112872_bib30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/rccm.201405-0992OC","article-title":"CXCR2 antagonist MK-7123. A phase 2 proof-of-concept trial for chronic obstructive pulmonary disease","volume":"191","author":"Rennard","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.ejmech.2020.112872_bib31","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/jamadermatol.2017.0725","article-title":"Immunotherapy of recurrent herpes labialis with squaric acid","volume":"153","author":"Palli","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ejmech.2020.112872_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.04.021","article-title":"A\u00a0phase 2, Multi-center, Placebo-controlled study of single dose squaric acid dibutyl ester (SADBE) to reduce frequency of outbreaks in subjects with recurrent herpes labialis","author":"Chang","year":"2020","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.ejmech.2020.112872_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1254\/fpj.95.5_247","article-title":"Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs","volume":"95","author":"Okabe","year":"1990","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"10.1016\/j.ejmech.2020.112872_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(95)00512-9","article-title":"Effect of a novel histamine H2 receptor antagonist, IT-066, on acute gastric injury induced by ischemia-reperfusion in rats, and its antioxidative properties","volume":"294","author":"Naito","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112872_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-4347(00)00099-2","article-title":"Development and validation of a liquid chromatographic\u2013tandem mass spectrometric method for the determination of pibutidine in human urine","volume":"740","author":"Kato","year":"2000","journal-title":"J.\u00a0Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.ejmech.2020.112872_bib36","first-page":"331","article-title":"Repeated dose toxicity study of 3-amino-4-[[(Z)-4-[[4-(piperidiomethyl)-2-pyridyl] oxy]-2-butenyl] amino]-3-cyclobutene-1, 2-dione monohydrochloride (Pibutidine hydrochloride) in rats (1): 13-week oral toxicity study with 4-week recovery test","volume":"27","author":"Oshima","year":"1999","journal-title":"Jpn. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2020.112872_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2036.1989.tb00248.x","article-title":"The effect of SK&F 94482 (BMY-25368) on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects","volume":"3","author":"Gavey","year":"1989","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2020.112872_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2036.1989.tb00217.x","article-title":"Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog","volume":"3","author":"Cavanagh","year":"1989","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2020.112872_bib39","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/acs.jmedchem.6b01358","article-title":"P, discovery of imidazo[1,2-a]pyridine ethers and squaramides as selective and potent inhibitors of mycobacterial adenosine triphosphate (ATP) synthesis","volume":"60","author":"Tantry","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib40","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.chempr.2019.02.027","article-title":"The versatility of squaramides: from supramolecular chemistry to chemical biology","volume":"5","author":"Marchetti","year":"2019","journal-title":"Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib41","first-page":"467","article-title":"Synthesis and application of thiosquaramides and their derivatives: a review, period","volume":"62","author":"Nagy","year":"2018","journal-title":"Polytech. Chem. Eng"},{"key":"10.1016\/j.ejmech.2020.112872_bib42","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/jm4017015","article-title":"Synthesis and biological evaluation of N, N\u2032-squaramides with high in\u00a0vivo efficacy and low toxicity: toward a low-cost drug against Chagas disease","volume":"57","author":"Olmo","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib43","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1039\/C0CC03989F","article-title":"Water-driven ligations using cyclic amino squarates: a class of useful SN1-like reactions","volume":"47","author":"Cui","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2020.112872_bib44","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1021\/jm00022a007","article-title":"A\u00a03-Amino-4-hydroxy-3-cyclobutene-1, 2-dione-Containing glutamate analog exhibiting high affinity to excitatory amino acid receptors","volume":"38","author":"Chan","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejmech.2016.08.047","article-title":"Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: synthesis, structural and functional characterisation","volume":"124","author":"Soukarieh","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib46","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1039\/c004165c","article-title":"Rationally designed squaryldiamides\u2013a novel class of sugar-nucleotide mimics?","volume":"8","author":"Niewiadomski","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib47","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bmc.2018.02.006","article-title":"Adenosine analogs bearing phosphate isosteres as human MDO1 ligands","volume":"26","author":"Zhang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib48","doi-asserted-by":"crossref","first-page":"12824","DOI":"10.1002\/slct.201803375","article-title":"Squaramide-based 5\u2019-phosphate replacements bind to the DNA repair exonuclease SNM1A","volume":"3","author":"D\u00fcrr","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2020.112872_bib49","doi-asserted-by":"crossref","first-page":"12715","DOI":"10.1021\/ja027131f","article-title":"Squaryl group as a new mimic of phosphate group in modified oligodeoxynucleotides: synthesis and properties of new oligodeoxynucleotide analogues containing an internucleotidic squaryldiamide linkage","volume":"124","author":"Sato","year":"2002","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112872_bib50","doi-asserted-by":"crossref","first-page":"13751","DOI":"10.1002\/ange.201606843","article-title":"Electrophilic RNA for peptidyl-RNA synthesis and site-specific cross-linking with tRNA-binding enzymes","volume":"128","author":"Fonvielle","year":"2016","journal-title":"Angew. Chemie"},{"key":"10.1016\/j.ejmech.2020.112872_bib51","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1021\/jo5020799","article-title":"Synthesis of base-modified 2\u2032-deoxyribonucleoside triphosphates and their use in enzymatic synthesis of modified DNA for applications in bioanalysis and chemical biology","volume":"79","author":"Hocek","year":"2014","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib52","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1021\/acs.accounts.9b00195","article-title":"Enzymatic synthesis of base-functionalized nucleic acids for sensing, cross-linking, and modulation of protein\u2013DNA binding and transcription","volume":"52","author":"Hocek","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112872_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ejmech.2020.112872_bib54","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","author":"Organization","year":"2015","journal-title":"Wkly. Epidemiol. Rec. Relev. \u00c9pid\u00e9miologique Hebd"},{"key":"10.1016\/j.ejmech.2020.112872_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exppara.2016.07.013","article-title":"Effective anti-leishmanial activity of minimalist squaramide-based compounds","volume":"170","author":"Mar\u00edn","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2020.112872_bib56","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bmc.2019.01.033","article-title":"\u00c1. Martin-Montes, E. Medina-Carmona, C. L\u00f3pez, C. Rotger, A. Costa, M. S\u00e1nchez-Moreno, Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB\/c mouse model","volume":"27","author":"Mart\u00edn-Escolano","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejmech.2013.08.037","article-title":"Squaric acid\/4-aminoquinoline conjugates: novel potent antiplasmodial agents","volume":"69","author":"Ribeiro","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib58","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.bmc.2016.03.005","article-title":"Novel squaramides with in\u00a0vitro liver stage antiplasmodial activity","volume":"24","author":"Ribeiro","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib59","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1039\/c2md20011b","article-title":"Squaric acid: a valuable scaffold for developing antimalarials?","volume":"3","author":"Kumar","year":"2012","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2020.112872_bib60","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1016\/j.bmc.2011.10.018","article-title":"Aza vinyl sulfones: synthesis and evaluation as antiplasmodial agents","volume":"19","author":"Gl\u00f3ria","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib61","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/cr500365f","article-title":"Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis","volume":"114","author":"Nagle","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.112872_bib62","series-title":"Chagas disease-epidemiology","author":"W.H. Organization","year":"2018"},{"key":"10.1016\/j.ejmech.2020.112872_bib63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cbpa.2006.03.004","article-title":"Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host","volume":"146","author":"Maya","year":"2007","journal-title":"Comp. Biochem. Physiol. Part A Mol. Integr. Physiol"},{"key":"10.1016\/j.ejmech.2020.112872_bib64","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2174\/156802611796575894","article-title":"Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives","volume":"11","author":"Wilkinson","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib65","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/0960-894X(96)00313-7","article-title":"Synthesis of a piperidinomethylthiophene derivative as H2-antagonist with inhibitory activity against Helicobacter pylori","volume":"6","author":"Kojima","year":"1996","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-2952(97)00416-4","article-title":"Structure\u2013activity characterization of an H2-receptor antagonist, 3-Amino-4-[4-[4-(1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2-dione hydrochloride (IT-066), involved in the insurmountable Antagonism against histamine-induced P","volume":"55","author":"Kijima","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112872_bib67","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/cbic.201000774","article-title":"Squaric acid monoamide mannosides as ligands for the bacterial lectin FimH: covalent inhibition or not?","volume":"12","author":"Grabosch","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2020.112872_bib68","first-page":"801","article-title":"A\u00a0bivalent glycopeptide to target two putative carbohydrate binding sites on FimH, Beilstein J","volume":"6","author":"Lindhorst","year":"2010","journal-title":"Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib69","series-title":"Glycosci. Microb. Adhes","first-page":"17","article-title":"Carbohydrate receptors of bacterial adhesins: implications and reflections","author":"Ohlsen","year":"2008"},{"key":"10.1016\/j.ejmech.2020.112872_bib70","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1021\/acs.jmedchem.5b00050","article-title":"X-ray crystal structures of Escherichia coli RNA polymerase with switch region binding inhibitors enable rational design of squaramides with an improved fraction unbound to human plasma protein","volume":"58","author":"Molodtsov","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib71","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1128\/JB.01103-12","article-title":"Novel rapidly diversifiable antimicrobial RNA polymerase switch region inhibitors with confirmed mode of action in Haemophilus influenzae","volume":"194","author":"Buurman","year":"2012","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2020.112872_bib72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A\u00a0diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science (80-. )"},{"key":"10.1016\/j.ejmech.2020.112872_bib73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tube.2016.11.006","article-title":"Advances in basic and translational tuberculosis research: proceedings of the first meeting of RePORT international","volume":"102","author":"Geadas","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2020.112872_bib74","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1039\/C5RA24521D","article-title":"Synthesis of luminescent squaramide monoesters: cytotoxicity and cell imaging studies in HeLa cells","volume":"6","author":"Fern\u00e1ndez-Moreira","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112872_bib75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmech.2013.04.046","article-title":"Synthesis and antitumor activity of novel 3, 4-diaryl squaric acid analogs","volume":"65","author":"Liu","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib76","doi-asserted-by":"crossref","first-page":"19196","DOI":"10.1039\/C4RA01216J","article-title":"Antifolate-modified iron oxide nanoparticles for targeted cancer therapy: inclusion vs. covalent union","volume":"4","author":"L\u00f3pez","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112872_bib77","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bmcl.2016.11.058","article-title":"Squarate-based carbocyclic nucleosides: syntheses, computational analyses and anticancer\/antiviral evaluation","volume":"27","author":"Lu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib78","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1039\/C5MD00515A","article-title":"Squaramides with cytotoxic activity against human gastric carcinoma cells HGC-27: synthesis and mechanism of action","volume":"7","author":"Quintana","year":"2016","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2020.112872_bib79","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/cmdc.201200157","article-title":"Cyclosquaramides as kinase inhibitors with anticancer activity","volume":"7","author":"Villalonga","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112872_bib80","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jinorgbio.2005.04.004","article-title":"Crystal structures and cytotoxicity of isopropylamine Pt (II) complexes: a trinuclear squarato-bridged [Pt3 (\u03bc2-C4O4) 3 (H2NPri) 6]\u00b7 3H2O and a mononuclear cis-[Pt (NO3) 2 (H2NPri) 2]","volume":"99","author":"Grabner","year":"2005","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2020.112872_bib81","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1039\/C9OB01133A","article-title":"A\u00a0hydroxamic-acid-containing nucleoside inhibits DNA repair nuclease SNM1A","volume":"17","author":"Doherty","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib82","series-title":"Hiv\/Aids Key Facts, 2018","author":"Organization","year":"2018"},{"key":"10.1016\/j.ejmech.2020.112872_bib83","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2016.03.004","article-title":"Current status and prospects of HIV treatment","volume":"18","author":"Cihlar","year":"2016","journal-title":"Curr. Opin. Virol"},{"key":"10.1016\/j.ejmech.2020.112872_bib84","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1016\/j.bmcl.2005.06.077","article-title":"Design and synthesis of a novel peptidomimetic inhibitor of HIV-1 Tat\u2013TAR interactions: squaryldiamide as a new potential bioisostere of unsubstituted guanidine","volume":"15","author":"Lee","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib85","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.bmcl.2019.08.006","article-title":"Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: design, synthesis, and biological evaluation","volume":"29","author":"Ghosh","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib86","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1021\/bi026783d","article-title":"IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase","volume":"42","author":"Feniger-Barish","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112872_bib87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2008.10.005","article-title":"CXCR2 antagonists for the treatment of pulmonary disease","volume":"121","author":"Chapman","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2020.112872_bib88","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1124\/mol.107.044610","article-title":"Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2","volume":"74","author":"Nicholls","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112872_bib89","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1476-5381.2009.00623.x","article-title":"A\u00a0common intracellular allosteric binding site for antagonists of the CXCR2 receptor","volume":"159","author":"Salchow","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112872_bib90","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tips.2006.08.001","article-title":"Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease","volume":"27","author":"Donnelly","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2020.112872_bib91","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/jpet.106.118927","article-title":"Pharmacological characterization of Sch527123, a potent allosteric CXCR1\/CXCR2 antagonist","volume":"322","author":"Gonsiorek","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2020.112872_bib92","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bmcl.2006.12.067","article-title":"Comparison of N, N\u2032-diarylsquaramides and N, N\u2032-diarylureas as antagonists of the CXCR2 chemokine receptor","volume":"17","author":"McCleland","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib93","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/13543776.18.6.629","article-title":"Phenol-containing antagonists of the CXCR2 receptor","volume":"18","author":"Busch-Petersen","year":"2008","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2020.112872_bib94","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2174\/156802610791561246","article-title":"Discovery of 3, 4-diaminocyclobut-3-ene-1, 2-dione-based CXCR2 receptor antagonists for the treatment of inflammatory disorders","volume":"10","author":"Dwyer","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib95","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1021\/acs.oprd.5b00072","article-title":"Early process development of a squaramide-based CXCR2 receptor antagonist","volume":"19","author":"Martin","year":"2015","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2020.112872_bib96","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/jm1013693","article-title":"Synopsis of some recent tactical application of bioisosteres in drug design","volume":"54","author":"Meanwell","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib97","first-page":"295","article-title":"Influence of isosteric replacements upon biological activity","volume":"206","author":"Friedman","year":"1951","journal-title":"Nasnrs"},{"key":"10.1016\/j.ejmech.2020.112872_bib98","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/0929867053363540","article-title":"Bioisosterism: a useful strategy for molecular modification and drug design","volume":"12","author":"Lima","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib99","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0960-894X(01)81269-5","article-title":"3-hydroxy-3-cyclobutene-1, 2-dione: application of novel carboxylic acid bioisostere to an in-vivo active non-tetrazole angiotensin-II antagonist","volume":"3","author":"Soll","year":"1993","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib100","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/jm00103a010","article-title":"Bioisosteric replacement of the. alpha.-amino carboxylic acid functionality in 2-amino-5-phosphonopentanoic acid yields unique 3, 4-diamino-3-cyclobutene-1, 2-dione containing NMDA antagonists","volume":"35","author":"Kinney","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib101","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1021\/jm9905099","article-title":"Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in\u00a0vivo bladder selectivity","volume":"43","author":"Butera","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib102","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1002\/ejoc.200500520","article-title":"Synthesis and properties of new nucleotide analogues possessing squaramide moieties as new phosphate isosters","volume":"2005","author":"Seio","year":"2005","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1021\/ol036121w","article-title":"Squaric acids: a new motif for designing inhibitors of protein tyrosine phosphatases","volume":"6","author":"Xie","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2020.112872_bib104","first-page":"1317","article-title":"The mechanism of diphtheria immunity and tetanus immunity in animals. 1890","volume":"28","author":"Von Behring","year":"1991","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejmech.2020.112872_bib105","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/anie.201509935","article-title":"A\u00a0synthetic glycopeptide vaccine for the induction of a monoclonal antibody that differentiates between normal and tumor mammary cells and enables the diagnosis of human pancreatic cancer","volume":"55","author":"Palitzsch","year":"2016","journal-title":"Angew. Chemie Int. Ed."},{"key":"10.1016\/j.ejmech.2020.112872_bib106","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cbic.201600699","article-title":"Conjugate vaccines from bacterial antigens by squaric acid chemistry: a closer look","volume":"18","author":"Xu","year":"2017","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2020.112872_bib107","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0404.1986.tb03524.x","article-title":"Neurotransmitter glutamate: its clinical importance","volume":"74","author":"Engelsen","year":"1986","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ejmech.2020.112872_bib108","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.bmcl.2010.01.050","article-title":"Exploration of a new series of PAR1 antagonists","volume":"20","author":"Planty","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib109","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0960-894X(01)00717-X","article-title":"Biphenyls as potent vitronectin receptor antagonists","volume":"12","author":"Urbahns","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib110","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1039\/C8CC04467H","article-title":"Squaryl group modified phosphoglycolipid analogs as potential modulators of GPR55","volume":"54","author":"Ding","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2020.112872_bib111","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.aab3516","article-title":"Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord","volume":"349","author":"Guy","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112872_bib112","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/j.bmcl.2006.06.090","article-title":"Exploring alternative Zn-binding groups in the design of HDAC inhibitors: squaric acid, N-hydroxyurea, and oxazoline analogues of SAHA","volume":"16","author":"Hanessian","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib113","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.bmcl.2018.06.029","article-title":"Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma","volume":"28","author":"Fournier","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib114","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/biom9080379","article-title":"Exploring structure-activity relationship in tacrine-squaramide derivatives as potent cholinesterase inhibitors","volume":"9","author":"Svobodova","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2020.112872_bib115","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.bmcl.2008.08.025","article-title":"Synthesis of a 200-member library of squaric acid N-hydroxylamide amides","volume":"18","author":"Charton","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib116","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1021\/jo0517848","article-title":"Squaric acid-based peptidic inhibitors of matrix metalloprotease-1","volume":"70","author":"Onaran","year":"2005","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112872_bib117","first-page":"35","article-title":"Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors","volume":"44","author":"Liedtke","year":"1998","journal-title":"Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.ejmech.2020.112872_bib118","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s000110050743","article-title":"Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis-targetting gelatinase A activation","volume":"50","author":"Jackson","year":"2001","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2020.112872_bib119","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/dbio.1994.1104","article-title":"Interstitial collagenase is required for angiogenesis in\u00a0vitro","volume":"162","author":"Fisher","year":"1994","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ejmech.2020.112872_bib120","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/cr9804543","article-title":"Design and therapeutic application of matrix metalloproteinase inhibitors","volume":"99","author":"Whittaker","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.112872_bib121","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1016\/j.bmcl.2012.10.009","article-title":"Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors","volume":"22","author":"Zhang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112872_bib123","article-title":"Squaramate-Modified Nucleotides and DNAfor Specific Cross-Linking with Lysine-Containing Peptides and Proteins","author":"Ivancov\u00e1","year":"2019","journal-title":"Angewandte Chemie"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420308448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420308448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:16:26Z","timestamp":1759328186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420308448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":122,"alternative-id":["S0223523420308448"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112872","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Squaric acid analogues in medicinal chemistry","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112872"}}